EPO Patents = 3

Forward Citations = 12

Loading Chart...

16 inventors (with patents filed for the assignee):

Qing Zhou (3 out of 5 patents)

Jun Lin (2 out of 13 patents)

Joe Zhou (2 out of 6 patents)

4. Weihong Nian (2 out of 3 patents)

5. Shaoxiong Wang (1 out of 4 patents)

6. Mengjun Shu (1 out of 1 patent)

7. Zhuzi He (1 out of 1 patent)

8. Rulei Chen (1 out of 1 patent)

9. Shu Shi (1 out of 1 patent)

10. Hongbin Yan (1 out of 1 patent)

11. Xiao Feng (1 out of 1 patent)

12. Lingyun Li (1 out of 1 patent)

13. Jianyang Zhao (1 out of 1 patent)

14. Jiuru Sun (1 out of 1 patent)

15. Xinxing Ma (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10253108 - Mutated antibody of fully humanized HER2 antibody, and encoding gene and use thereof (2019-04-09),

2. 10017555 - Long-acting blood sugar decreasing fusion protein (2018-07-10),

3. 9896510 - Anti-human RANKL antibody, humanized antibody of the same, and pharmaceutical composition and use thereof (2018-02-20),

4. 8926972 - Anti-angiogenesis fusion proteins (2015-01-06),

Genor Biopharma Co., Ltd. is a leading biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies for patients worldwide. With a focus on oncology and immunology, Genor is committed to bringing life-saving and life-improving treatments to those in need. Through strategic partnerships and a strong pipeline of products, Genor strives to make a positive impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#471 in Shanghai

#5,620 in China

Shanghai, China

Genor Biopharma Co., Ltd.